The healthcare landscape is experiencing a development with the arrival of GLP-1 transdermal systems . These exciting formulations offer a promising alternative to delivering glucagon-like peptide-1 drugs for individuals managing type 2 diabetes . Instead of injections , a easy-to-use patch affix